Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.
Elad MashiachJuan Diego AlzateFernando De Nigris VasconcellosKenneth BernsteinBernadine R DonahueZane SchnurmanJason GurewitzLauren E RotmanSylvia AdamsMarleen MeyersRuth OratzYelena NovikMaryann J KwaJoshua S SilvermanErik P SulmanJohn G GolfinosDouglas KondziolkaPublished in: Neurosurgery (2023)
Patients with BCBM can achieve long-term survival. The use of TT and HER2+ disease are associated with long-term survival. The primary cause of death was extracranial disease progression, and none of the patients living ≥5 years died of CNS-related disease.